Single-Use Technologies for Biopharmaceuticals: Global Markets
Report Highlights
The global market for single-use technologies for biopharmaceuticals was valued at $720 million in 2011 and should reach $985.2 million in 2012. Total market value is expected to reach nearly $2.4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.1%.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns
- Comprehensive company profiles of existing and potential market players
- Patent analysis.
The study includes the following major elements, Executive summary, Revenues forecast through 2017, Analysis of the key factors influencing market demand, Market intelligence, Key trends across geographies, Key trends, opportunities and market estimates within each of the markets specified General assessment of expected market trends in the longer term (2012 to 2017) Competitive environment—Key companies, top strategies and recent developments and market intelligence. Company profiles Patent analysis Specifically excluded from the report are market estimates of biopharmaceutical drugs and devices. However, an overview of the market for biopharmaceutical drugs is given to provide a holistic view of the market. The report covers only single-use technologies or disposables used in biopharmaceutical manufacturing. The report also excludes control software or custom designed software used with single-use biopharmaceutical manufacturing technologies